Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(1): 3-6


Prevalence of cancer cases among population of Kirkuk, Iraq from 2016-2020

Hussein Ali Mohammed, Jenan Akbar Shakoor, Nazar Ahmed Mahmood, Abid Salih Kumait, Araz Mohammed Kareem.




Abstract

Objective: To present a clear picture of the cancer cases reported in Kirkuk between 2016 and 2020 and to identify the top 10 instances in both genders.
Methodology: This cohort/retrospective study was conducted at oncology/hematology center in Kirkuk governorate from January, 2021 to May, 2022. The data were collected from the official records of oncology/hematology center in Kirkuk governorate and consisted of 4917 cancer cases during the five years period from 2016 to 2020.
Results: A total of 4719 cases of all cancer types in Kirkuk were recorded from 2016-2020. Of these, 64.2% were females and 35.8% males. Age of 65.8% cases was between 41-70 years, with a mean of 52.624±22.593 years. For both genders, breast cancer was the most common (1532), followed by lung cancer.
Conclusion: Breast cancer is on the top of ten cancers and is on the rising trend. The Ministry of health should plan for a strategy of regular screening for breast cancer in women and increasing the awareness of the women regarding breast self-examination for early detection.

Key words: Prevalence, cancer, lung cancer, breast cancer, Kirkuk, Iraq.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.